By Scientia Professor John Martin Kaldor

Journal articles

Butler T; Robertson PW; Kaldor JM; Donovan BJ; Butler , 2001, 'Syphilis in New South Wales (Australia) prisons', International Journal of STD and AIDS, 12, pp. 376 - 379

McDonald AM; Donovan BJ; O Connor C; Packham D; Patten J; Chuah J; Waddell R; Fairley CK; Kaldor JM, 2001, 'Time trends in HIV incidence among homosexually active men seen at sexual health clinics in Australia, 1993-1999.', Journal of Clinical Virology, pp. 297 - 303

McDonald AM; Li Y; Cruickshank M; Elliot E; Kaldor JM; Ziegler JB, 2001, 'Use of interventions for reducing mother-to-child transmission of HIV in Australia', Medical Journal of Australia, 174, pp. 449 - 452

Correll PK; Law MG; Seed CR; Gust A; Buring M; Dax E; Keller AJ; Kaldor JM, 2001, 'Variant Cruetzfeldt-Jakob disease in Australian blood donors: estimation of risk and the impact of deferral strategies', Vox Sanguinis, pp. 6 - 11

Dore GJ; Kaldor JM, 2000, 'Detection of HCV RNA in semen', LANCET, 356, pp. 1520 - 1520, http://dx.doi.org/10.1016/S0140-6736(00)02890-7

Dore GJ; Kaldor JM; Leruez-Ville M; Rouzioux C; Chaix ML, 2000, 'Detection of HCV RNA in semen [1] (multiple letters)', Lancet, 356, pp. 1520, http://dx.doi.org/10.1016/S0140-6736(00)02890-7

Li Y; McDonald AM; Dore GJ; Kaldor JM, 2000, 'Improving survival following AIDS in Australia, 1991-1996. National HIV Surveillance Committee.', AIDS, 14, pp. 2349 - 2354, http://dx.doi.org/10.1097/00002030-200010200-00016

Freeman AJ; Dore GJ; Law MG; Thorpe M; Von Overbeck J; Lloyd AR; Marinos G; Kaldor JM, 2000, 'The natural history of chronic hepatitis C: A systematic review', HEPATOLOGY, 32, pp. 422A - 422A, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000089622401038&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Dabis F; Marimoutou C; Meyer L; Boufassa F; Hamouda O; Brunn M; Pezzotti P; Rezza G; Lorenzo JI; Touloumi G; Hatzakis A; Karafoulidou A; Katsarou O; Brettle R; Del Amo J; Del Romero J; Prins M; Coutinho RA; Van Benthem B; Coutinho RA; Kirk O; Pedersen C; Hernandez Aguado I; Perez-Hoyos S; Eskild A; Bruun JN; Sannes M; Sabin C; Lee C; Johnson AM; Phillips AN; Babiker A; Darbyshire JH; Gill N; Porter K; Egger M; Francioli P; Rickenbach M; Cooper D; Kaldor J; Vizzard J; Tusell JM; Ruiz I; Cayla JA; Garcia de Olalla P; Day NE; De Angelis D, 2000, 'Effect of ignoring the time of HIV seroconversion in estimating changes in survival over calendar time in observational studies: Results from CASCADE', AIDS, 14, pp. 1899 - 1906, http://dx.doi.org/10.1097/00002030-200009080-00003

Guthrie JA; Dore GJ; McDonald AM; Kaldor JM, 2000, 'HIV and AIDS in aboriginal and Torres Strait Islander Australians: 1992-1998. The National HIV Surveillance Committee.', Med J Aust, 172, pp. 266 - 269, https://www.ncbi.nlm.nih.gov/pubmed/10860091

Kaldor JM; Dore GJ; Correll PKL, 2000, 'Public health challenges in hepatitis C virus infection', Journal of Gastroenterology and Hepatology (Australia), 15, http://dx.doi.org/10.1046/j.1440-1746.2000.02134.x

Grulich AE; Wan X; Law MG; Milliken ST; Lewis CR; Garsia R; Gold J; Finlayson R; Kaldor JM, 2000, 'B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin¿s lymphoma in people with AIDS', AIDS, 14, pp. 133 - 140

Clegg AO; Ashton LJ; Biti RA; Badhwar P; Williamson PM; Kaldor JM; Stewart GA; And TAL-T, 2000, 'CCR5 promoter polymorphisms, CCR5 59029A and CCR5 59353C, are under represented in HIV-1 infected long-term non-progressors.', AIDS, 14, pp. 103 - 108

Rhodes DI; Ashton LJ; Solomon A; Carr AD; Cooper DA; Kaldor JM; Deacon N; For TAL-T, 2000, 'Characterization of three nef-defective human immunodeficiency virus type 1 strains associated with long-term nonprogression', Journal of Virology, pp. 10581 - 10588

Dore GJ; Kaldor JM, 2000, 'Detection of HCV RNA in semen (letter)', Lancet, pp. 1520 - 1520

Law MG; Li Y; McDonald AM; Cooper DA; Kaldor JM, 2000, 'Estimating the population impact in Australia of improved antiretroviral treatment for HIV infection', AIDS, 14, pp. 197 - 201

MacDonald MA; Wodak AD; Dolan K; Van Beek IA; Cunningham PH; Kaldor JM, 2000, 'Hepatitis C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997', Medical Journal of Australia, 172, pp. 57 - 61

Wodak AD; Van Beek IA; Kaldor JM, 2000, 'Hepatitus C virus antibody prevalence among injecting drug users at selected needle and syringe programs in Australia, 1995-1997', Medical Journal of Australia, 172, pp. 57 - 61

Butler T; Donovan BJ; Taylor J; Cunningham AL; Mindel A; Levy MT; Kaldor JM; Butler , 2000, 'Herpes simplex virus type 2 in prisoners, New South Wales, Australia', International Journal of STD and AIDS, 11, pp. 743 - 747

Guthrie J; Dore GJ; McDonald AM; Kaldor JM; For TNHS, 2000, 'HIV and AIDS in Aboriginal and Torres Strait Islander Australians:1992-1998', Medical Journal of Australia, 172, pp. 266 - 269

Li Y; McDonald AM; Dore GJ; Kaldor JM; For TNHS, 2000, 'Improving survival following AIDS in Australia, 1991-1996', AIDS, 14, pp. 2349 - 2354

Irwin M; Carr A; Kaldor J, 2000, 'P37 The relationship between physical activity and HIV lipodystrophy syndrome in protease inhibitor recipients', HIV Medicine, 1, pp. 184 - 184, http://dx.doi.org/10.1046/j.1468-1293.2000.00024-121.x

Law MG; Roberts S; Dore GJ; Kaldor JM, 2000, 'Primary hepatocellular carcinoma in Australia, 1978-1997: increasing incidence and mortality', Medical Journal of Australia, 173, pp. 403 - 405

Kaldor JM, 2000, 'Reflections on a decade of HIV/AIDS surveillance in Australia', Australian HIV Surveillance Report, 16, pp. 1 - 4

Ashton LJ; Kaldor JM, 2000, 'The historical development of epidemiological methods for studying HIV-1 disease progression', Journal of Epidemiology and Biostatistics, 5, pp. 67 - 78

Kaldor JM; Dore GJ; Correll PK, 2000, 'Towards control of hepatitis C in the Asia-Pacific region ¿ Public health challenges in hepatitis C virus infection', Journal of Gastroenterology and Hepatology, 15, pp. E83 - E90

Sullivan LG; Crofts JN; Aitken CK; Kaldor JM, 1999, 'The force of numbers: Why hepatitis C is spreading among Australian injecting drug users while HIV is not (multiple letters) [3]', Medical Journal of Australia, 171, pp. 165 - 166, http://dx.doi.org/10.5694/j.1326-5377.1999.tb123582.x

Correll PK; Law MG; McDonald AM; Cooper DA; Kaldor JM, 1999, 'HIV disease progression in Australia in the time of combination antiretroviral therapies', MEDICAL JOURNAL OF AUSTRALIA, 170, pp. 285 - 285, http://dx.doi.org/10.5694/j.1326-5377.1999.tb127767.x

Crofts N; Aitken CK; Kaldor JM, 1999, 'The force of numbers: Why hepatitis C is spreading among Australian injecting drug users while HIV is not', Medical Journal of Australia, 170, pp. 220 - 221, http://dx.doi.org/10.5694/j.1326-5377.1999.tb140325.x

Kelly P; Cummings R; Kaldor JM; Irwig L, 1999, 'A new, clinically-based algorithm for the diagnosis of HIV in African tuberculosis patients: cross-sectional analysis from Mzuzu, Malawi', International Journal of STD and AIDS, 10, pp. 231 - 236

Grulich AE; Kaldor JM, 1999, 'AEA response to proposed Australian National Privacy Legislation', Australasian Epidemiologist, pp. 14 - 15

Law MG; De Winter L; McDonald AM; Cooper DA; Kaldor JM, 1999, 'AIDS-diagnoses at higher CD4 counts in Australia following the introduction of highly active antiretroviral treatment', AIDS, 13, pp. 263 - 269

Dore GJ; Correll PK; Li Y; Kaldor JM; Cooper DA; Brew BJ, 1999, 'Changes to AIDS dementia complex in the era of highly active antiretroviral therapy', AIDS, 13, pp. 1249 - 1253

Kelly P; Cumming RG; Kaldor JM, 1999, 'HIV and tuberculosis in rural sub-Saharan Africa: a cohort study with two year follow-up', Transactions of the Royal Society of Tropical Medicine and Hygiene, pp. 287 - 293

Correll PK; Law MG; McDonald AM; Cooper DA; Kaldor JM, 1999, 'HIV disease progression in Australia in the time of combination antiretroviral therapies. (Author's reply)', Medical Journal of Australia, 170, pp. 285 - 285 (letter)

McDonald AM; Ryan JL; Brown PJ; Manners CJ; Falconer AD; Kinnear RC; Harvey WJ; Hearne PR; Banaszczyk M; Kaldor JM, 1999, 'HIV prevalence at reception into Australian prisons, 1991-1997', Medical Journal of Australia, 171, pp. 18 - 21, https://www.ncbi.nlm.nih.gov/pubmed/10451666

Westley-Wise VJ; Stewart BW; Kreis I; Ricci PF; Hogan AL; Darling C; Corbett S; Kaldor JM; Stacey NH; Warburton P, 1999, 'Investigation of a cluster of leukaemia in the Illawarra region of New South Wales', Medical Journal of Australia, 171, pp. 178 - 183

Westley-Wise VJ; Stewart BW; Kreis I; Ricci PF; Hogan AL; Darling C; Corbett S; Kaldor JM; Stacey NH; Warburton P, 1999, 'Investigation of a cluster of leukaemia in the Illawarra region of New South Wales, 1989-1996', Medical Journal of Australia, 171, pp. 178 - 183

Grulich AE; Olsen SJ; Luo K; Hendry O; Cunningham PH; Cooper DA; Gao SJ; Chang Y; Moore PH; Kaldor JM, 1999, 'Kaposi¿s sarcoma-associated herpesvirus: a sexually transmissible infection?', Journal of acquired immune deficiency syndrome and human retrovirology, 20, pp. 387 - 393

Dore GJ; Law MG; Kaldor JM, 1999, 'Prevalence of hepatitis C virus infection in the United States', New England Journal of Medicine, pp. 2093 - 2094 (lett

Grulich AE; Wan X; Law MG; Coates ML; Kaldor JM, 1999, 'Risk of cancer in people with AIDS', AIDS, 13, pp. 839 - 843

Butler T; Spencer J; Cui JS; Vickery K; Zou J; Kaldor JM; Butler , 1999, 'Seroprevalence of markers for hepatitis B, C and G in male and female prisoners ¿ NSW, 1996', Australian and New Zealand Journal of Public Health, pp. 377 - 384

Collins SL; Law MG; Fletcher A; Boyd AW; Kaldor JM; Masters C, 1999, 'Surgical treatment and risk of sporadic Creutzfeldt-Jacob disease: a case-control study', The Lancet, pp. 693 - 697

Crofts N; Aitken CK; Kaldor JM, 1999, 'The force of numbers: why hepatitis C is spreading among injecting Australian drug users while HIV is not', Medical Journal of Australia, 170, pp. 220 - 221

Crofts N; Aitken CK; Kaldor JM, 1999, 'The force of numbers: why hepatitis C is spreading among injecting Australian drug users while HIV is not. (Author¿s reply)', Medical Journal of Australia, 171, pp. 165 - 166 (lette

Crofts N; Loveday S; Kaldor JM, 1999, 'The meaning of hepatitis C for the community', Australian Family Physician, pp. 60 - 63

Collignon P; Dore GJ; Li Y; Plant AJ; Kaldor JM, 1998, 'Trends in infectious disease mortality rates (multiple letters) [3]', Medical Journal of Australia, 169, http://dx.doi.org/10.5694/j.1326-5377.1998.tb126845.x

Kippax S; Rosenthal D; Dowsett G; Kaldor J; Crofts N; McCallum L; Brotherton A, 1998, 'AIDS impact.', AIDS care, 10 Suppl 2

Dore GJ; Kaldor JM; McCaughan GW, 1998, 'Polymerase chain reaction as marker of infectivity in people with hepatitis C - Summary vertical transmission rates may be misleading - Reply', BRITISH MEDICAL JOURNAL, 316, pp. 554 - 554, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000072097400048&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Thomas S; Hall A; Newell ML; Dore GJ; Kaldor JM; McCaughan GW, 1998, 'Polymerase chain reaction as marker of infectivity in people with hepatitis C (multiple letters) [5]', British Medical Journal, 316, pp. 553 - 554

Back to profile page